BridgeBio Pharma
BBIO· Manufacturing· Market cap · Fiscal year ends in December
Neil Kumar, Ph.D. is the CEO of BridgeBio Pharma and was paid $15.6M in FY2024 (Dec), up 28%.
Executives3
See all- 1Neil Kumar, Ph.D.Chief Executive OfficerFY2024
- 2Thomas Trimarchi, Ph.D.President and Chief Financial OfficerFY2024
- 3Brian Stephenson, Ph.D., CFAFormer Chief Financial OfficerFY2024
Named executives and their total pay, from the Summary Compensation Table of the latest proxy.
Pay
See allBridgeBio Pharma paid its 3 named executives $27.7M in total in FY2024 (Dec). CEO Neil Kumar, Ph.D. was paid $15.6M of that.
| Name | |||
|---|---|---|---|
| Neil Kumar, Ph.D.Chief Executive Officer | |||
| Thomas Trimarchi, Ph.D.President and Chief Financial Officer | Not disclosed | Not disclosed | |
| Brian Stephenson, Ph.D., CFAFormer Chief Financial Officer |
of each named executive, from the Summary Compensation Table of each proxy.
Peers21
See allThe FY2025 (Dec) proxy of BridgeBio Pharma names 21 peer companies for pay. Among BridgeBio Pharma and these peers, CEO pay was 6th highest of 9 and total shareholder return was 8th highest of 9.
6th highest of 9in BridgeBio Pharma and its pay peers, FY2025 (Dec) by CEO pay:
8th highest of 9in BridgeBio Pharma and its pay peers, FY2025 (Dec) by total shareholder return:
;fill-rule:nonzero'/%3e%3cpath%20d='M1148.33%20186.308c58.75%20119.583%2018.75%20283.333-97.916%20430.416h138.333c104.583-146.25%20137.917-305.416%2072.917-430.416C1163.33-3.276%20872.914-51.609%20575.83%2057.141c262.084-84.583%20494.167-31.25%20572.5%20129.167'%20style='fill:url(%23svg__ptc-logo-color__b);fill-rule:nonzero'/%3e%3cpath%20d='M121.25%20447.558V94.224h152.5c63.75%200%20122.917%2032.084%20122.917%20105.417%200%2021.667-8.334%20107.5-138.334%20107.5h-45v140.417zm128.333-200.417c47.084%200%2054.584-30%2054.584-44.583%200-35-28.334-42.917-55.417-42.917h-35.417v87.5zM790.417%20270.891c0-72.083%2051.666-119.167%20122.083-119.167%2019.583%200%2035.417%203.75%2048.75%208.75l35.417-60.416c-32.5-10.834-72.084-14.584-95-14.584-130.417%200-207.084%2085-207.084%20189.584%200%20127.5%20105.417%20181.666%20196.667%20181.666%2043.333%200%2064.583-5.416%2078.75-9.583l42.917-74.167c-24.167%2010.417-59.584%2019.167-91.667%2019.167-92.083-.417-130.833-61.667-130.833-121.25M138.75%20526.308h-17.917v-16.25h53.75v15.833h-17.916v90.833h-18.334v-90.416zM192.917%20617.141V510.058h18.333v43.333h19.583v-43.333h18.334v106.666h-18.334v-47.5H211.25v47.5h-18.333zM274.167%20617.141V510.058h49.166v15.833H292.5v27.5h23.75v15.833H292.5v31.25h32.917v15.834h-51.25zM365.833%20617.141H347.5V510.058h25.833c20.417%200%2031.25%208.75%2031.25%2031.666%200%2017.084-6.666%2024.167-12.916%2027.084l15.416%2048.333h-18.75l-12.916-44.167c-2.5.417-6.25.417-9.584.417zm0-59.167h6.667c10%200%2013.75-3.75%2013.75-16.25%200-12.916-3.75-16.25-13.75-16.25h-6.667zM438.75%20617.141h-17.917l19.584-106.667h22.916l19.584%20106.667H465l-3.333-23.75h-20zm5.833-39.583h14.584l-7.084-45.834zM501.25%20617.141V510.058h26.25c22.5%200%2033.333%208.75%2033.333%2031.666%200%2022.917-10.416%2031.667-33.333%2031.667h-7.917v43.75zm18.333-59.167h7.084c12.083%200%2015.833-3.75%2015.833-16.25%200-12.916-3.75-16.25-15.833-16.25h-7.084zM579.583%20617.141V510.058h49.167v15.833h-30.833v27.5h23.75v15.833h-23.75v31.25h32.916v15.834h-51.25zM652.5%20510.058h18.333v80.416c0%207.917%202.917%2011.667%209.584%2011.667s9.583-3.75%209.583-11.667v-80.416h18.333v80c0%2018.333-10.833%2028.333-27.916%2028.333-17.5%200-27.917-10-27.917-28.333zM744.583%20526.308h-17.916v-16.25h53.75v15.833H762.5v90.833h-18.333v-90.416zM801.25%20617.141V510.058h18.333v106.666H801.25zM884.167%20545.891v-8.333c0-9.167-4.167-12.917-8.75-12.917-7.5%200-9.584%203.75-9.584%2011.667v54.166c0%207.917%202.5%2011.667%209.584%2011.667%206.666%200%208.75-3.75%208.75-10.833v-12.917H902.5v12.083c0%2015-8.75%2027.5-27.083%2027.5-19.167%200-27.917-12.083-27.917-27.5v-55c0-15%208.75-27.5%2027.917-27.5%2018.333%200%2027.083%2013.334%2027.083%2029.167v7.917h-18.333zM962.083%20536.724c-.833-9.166-5.416-11.666-9.583-11.666-5.833%200-9.167%203.75-9.167%2010.416%200%2018.334%2037.084%2027.084%2037.084%2055.834%200%2017.5-11.667%2027.5-29.167%2027.5-17.083%200-26.667-13.75-27.5-29.584l17.5-2.5c.833%2010.834%205%2016.25%2010.833%2016.25%206.25%200%2010.834-3.333%2010.834-9.583%200-21.25-37.084-26.667-37.084-57.5%200-17.083%2010.417-26.667%2028.334-26.667%2015%200%2023.75%2010.834%2025.416%2025.834zM511.25%20447.558v-283.75H410.417V94.224h293.75v69.584h-100v283.75zM1230.42%20589.224h9.583v27.5h5.833v-27.5h9.584v-4.583h-25zM1286.25%20584.641l-9.167%2023.75-9.166-23.75h-8.334v32.083H1265v-25.833l10.417%2025.417v.416h3.333l10.417-25.833v25.833h5.416v-32.083z'%20style='fill:%23373153;fill-rule:nonzero'/%3e%3cdefs%3e%3clinearGradient%20id='svg__ptc-logo-color__a'%20x1='0'%20x2='1'%20y1='0'%20y2='0'%20gradientTransform='rotate(84.319%20-153.165%20165.88)scale(432.1524)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0'%20style='stop-color:%23f79f5d;stop-opacity:1'/%3e%3cstop%20offset='1'%20style='stop-color:%23e84c38;stop-opacity:1'/%3e%3c/linearGradient%3e%3clinearGradient%20id='svg__ptc-logo-color__b'%20x1='0'%20x2='1'%20y1='0'%20y2='0'%20gradientTransform='rotate(84.319%20352.385%20623.618)scale(432.1755)'%20gradientUnits='userSpaceOnUse'%3e%3cstop%20offset='0'%20style='stop-color:%23f79f5d;stop-opacity:1'/%3e%3cstop%20offset='1'%20style='stop-color:%23e84c38;stop-opacity:1'/%3e%3c/linearGradient%3e%3c/defs%3e%3c/svg%3e)
%20scale(0.100000,-0.100000)'%20fill='%23000000'%20stroke='none'%3e%3cpath%20d='M3195%205489%20c-380%20-49%20-706%20-317%20-831%20-682%20-56%20-163%20-54%20-112%20-54%20-1773%20l0%20-1534%20590%200%20590%200%200%201465%200%201465%20600%200%20600%200%200%20535%200%20535%20-712%20-1%20c-392%20-1%20-744%20-6%20-783%20-10z'/%3e%3c/g%3e%3c/svg%3e)
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.
Board1
See all- Charles Homcy, M.D.Director · 6 yr on the boardIndependent—Paid as an executive
The board of the latest proxy (FY2024).
Activity
Filings6
See all| Proxy statement | DEF 14A | Apr 24, 2026 | FY2025 |
| Annual report | 10-K | Feb 24, 2026 | FY2025 |
| Proxy statement | DEF 14A | Apr 30, 2025 | FY2024 |
| Annual report | 10-K | Feb 20, 2025 | FY2024 |
| Proxy statement | DEF 14A | Apr 25, 2024 | FY2023 |
| Annual report | 10-K | Feb 22, 2024 | FY2023 |
